Toll Free: 1-888-928-9744

Pfenex Inc. - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 40 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Pfenex Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Pfenex Inc. - Product Pipeline Review - 2014', provides an overview of the Pfenex Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pfenex Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Pfenex Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Pfenex Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Pfenex Inc.'s pipeline products

Reasons to buy

- Evaluate Pfenex Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Pfenex Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Pfenex Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Pfenex Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pfenex Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Pfenex Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Pfenex Inc. Snapshot 5
Pfenex Inc. Overview 5
Key Information 5
Key Facts 5
Pfenex Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Pfenex Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Pfenex Inc. - Pipeline Products Glance 13
Pfenex Inc. - Clinical Stage Pipeline Products 13
Phase I Products/Combination Treatment Modalities 13
Pfenex Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Pfenex Inc. - Drug Profiles 16
ranibizumab biosimilar 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
certolizumab pegol biosimilar 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
filgrastim 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
interferon beta-1b 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
parathyroid hormone biosimilar 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
pegaspargase biosimilar 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
pegfilgrastim 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
peginterferon alfa-2a 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
peginterferon alfa-2b 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Px-533 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Px-563L 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
somatropin biosimilar 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Second Generation Px-563L 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Pfenex Inc. - Pipeline Analysis 30
Pfenex Inc. - Pipeline Products by Target 30
Pfenex Inc. - Pipeline Products by Route of Administration 32
Pfenex Inc. - Pipeline Products by Molecule Type 33
Pfenex Inc. - Pipeline Products by Mechanism of Action 34
Pfenex Inc. - Recent Pipeline Updates 35
Pfenex Inc. - Dormant Projects 37
Pfenex Inc. - Locations And Subsidiaries 38
Head Office 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 40
Disclaimer 40
List of Tables
Pfenex Inc., Key Information 5
Pfenex Inc., Key Facts 5
Pfenex Inc. - Pipeline by Indication, 2014 8
Pfenex Inc. - Pipeline by Stage of Development, 2014 9
Pfenex Inc. - Monotherapy Products in Pipeline, 2014 10
Pfenex Inc. - Partnered Products in Pipeline, 2014 11
Pfenex Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12
Pfenex Inc. - Phase I, 2014 13
Pfenex Inc. - Preclinical, 2014 14
Pfenex Inc. - Discovery, 2014 15
Pfenex Inc. - Pipeline by Target, 2014 31
Pfenex Inc. - Pipeline by Route of Administration, 2014 32
Pfenex Inc. - Pipeline by Molecule Type, 2014 33
Pfenex Inc. - Pipeline Products by Mechanism of Action, 2014 34
Pfenex Inc. - Recent Pipeline Updates, 2014 35
Pfenex Inc. - Dormant Developmental Projects,2014 37 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify